Michael A. Gordon - 20 Feb 2026 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Feb 2026, 18:25:57 UTC
Prior SEC filing
02 Oct 2025
Next SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael A. Gordon

Key filing fact

Michael A. Gordon filed Form 4 for Lucid Diagnostics Inc. (LUCD) on 24 Feb 2026.

Key facts

  • This page summarizes Michael A. Gordon's Form 4 filing for Lucid Diagnostics Inc. (LUCD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2026, 18:25.

Change

  • Previous filing in this sequence was filed on 02 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001932934 Primary reporting owner

Gordon Michael Adam

Relationship
General Counsel and Secretary
Address
360 MADISON AVENUE, 25TH FLOOR, NEW YORK
Signature
/s/ Michael A. Gordon
Signature date
24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LUCD transaction

Common stock

Award

Transaction value
$0
Shares
+300,000
Change %
+43%
Price
$0.000000
Shares after
1,000,000
Date
20 Feb 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .